MLTX
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) has 7 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 21, 2026.
The most active filer is Chief Scientific Officer Reich Kristian with 5 filings. Insiders have net sold $8.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jorge Santos da Silva
- Employees:100
- HQ:Zug, CH
- IPO:2020-10-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$1.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 43,700 | $878K | Jul 21 | SEC ↗ | |
| Chief Scientific Officer | Sale | 16,105 | $322K | Jul 20 | SEC ↗ | |
| Chief Executive Officer | Sale | 33,936 | $679K | Jul 13 | SEC ↗ | |
| Chief Executive Officer | Sale | 68,289 | $1.4M | Jul 13 | SEC ↗ | |
Santos da Silva JorgeFirst filing | Chief Executive Officer | Sale | 47,775 | $957K | Jul 2 | SEC ↗ |
| Chief Financial Officer | Sale | 39,120 | $862K | Jun 23 | SEC ↗ | |
Bodenstedt MatthiasFirst filing | Chief Financial Officer | Sale | 15,082 | $297K | Jun 18 | SEC ↗ |
Bodenstedt MatthiasFirst filing | Chief Financial Officer | Sale | 2,794 | $55K | Jun 18 | SEC ↗ |
Reich KristianFirst filing | Chief Scientific Officer | Sale | 50,000 | $945K | Jun 17 | SEC ↗ |
Reich KristianFirst filing | Chief Scientific Officer | Sale | 50,000 | $935K | Jun 17 | SEC ↗ |
Reich KristianFirst filing | Chief Scientific Officer | Sale | 50,000 | $972K | Jun 17 | SEC ↗ |
Related companies
MoonLake Immunotherapeutics is in the Healthcare sector.